The Emerging Roles and Mechanisms of PAQR3 in Human Cancer: Pathophysiology and Therapeutic Implications

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Ghafoor Q, Baijal S, Taniere P, O’Sullivan B, Evans M, Middleton G. Epidermal Growth Factor Receptor (EGFR) kinase inhibitors and non-small cell lung cancer (NSCLC) - advances in molecular diagnostic techniques to facilitate targeted therapy. Pathol Oncol Res. 2018;24(4):723–731. doi:10.1007/s12253-017-0377-1
   PubMed Web of Science ®Google Scholar
• Hsu PC, Jablons DM, Yang CT, You L. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC). Int J Mol Sci. 2019;20(15):3821. doi:10.3390/ijms20153821
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang M, Guo Q, Xu H, Yang Z, Li D. The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis. Gene. 2022;816:146173. doi:10.1016/j.gene.2021.146173
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–196. doi:10.1016/j.ejphar.2018.07.034
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Nandi S. Synthetic lethality in DNA repair network: a novel avenue in targeted cancer therapy and combination therapeutics. IUBMB Life. 2017;69(12):929–937. doi:10.1002/iub.1696
   PubMed Web of Science ®Google Scholar
• Villa NY, Moussatche P, Chamberlin SG, Kumar A, Lyons TJ. Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets. J Mol Evol. 2011;73(3–4):134–152. doi:10.1007/s00239-011-9462-3
   PubMed Web of Science ®Google Scholar
• Huang M, Zhao Z, Cao Q, et al. PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9. Metabolism. 2019;94:88–95. doi:10.1016/j.metabol.2019.02.005
   PubMed Web of Science ®Google Scholar
• Lei L, Ling ZN, Chen XL, Hong LL, Ling ZQ. Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization. Cancer Manag Res. 2020;12:353–362. doi:10.2147/CMAR.S210919
   PubMed Web of Science ®Google Scholar
• Fan F, Feng L, He J, et al. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells. Carcinogenesis. 2008;29(6):1157–1163. doi:10.1093/carcin/bgn119
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Fan F, et al. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis. 2012;33(11):2228–2235. doi:10.1093/carcin/bgs245
   PubMed Web of Science ®Google Scholar
• Ling ZQ, Guo W, Lu XX, et al. A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers. Ann Oncol. 2014;25(7):1363–1372. doi:10.1093/annonc/mdu168
   PubMed Web of Science ®Google Scholar
• Ma Z, Wang Y, Piao T, et al. The tumor suppressor role of PAQR3 in osteosarcoma. Tumour Biol. 2015;36(5):3319–3324. doi:10.1007/s13277-014-2964-z
   PubMedGoogle Scholar
• Tang SL, Gao YL, Hu WZ. PAQR3 inhibits the proliferation, migration and invasion in human glioma cells. Biomed Pharmacother. 2017;92:24–32. doi:10.1016/j.biopha.2017.05.046
   PubMed Web of Science ®Google Scholar
• Tang YT, Hu T, Arterburn M, et al. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol. 2005;61(3):372–380. doi:10.1007/s00239-004-0375-2
   PubMed Web of Science ®Google Scholar
• Luo X, Feng L, Jiang X, et al. Characterization of the topology and functional domains of RKTG. Biochem J. 2008;414(3):399–406. doi:10.1042/BJ20080948
   PubMedGoogle Scholar
• Fu Y, Jia X, Yuan J, et al. Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates. Dev Cell. 2023;58:398–415.e7. doi:10.1016/j.devcel.2023.02.006
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shao L, Wang Y, Luo X. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling. Biochem Biophys Res Commun. 2019;509(3):746–752. doi:10.1016/j.bbrc.2018.12.176
   PubMed Web of Science ®Google Scholar
• Li X, Li M, Chen D, Shi G, Zhao H. PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer. Arch Med Sci. 2018;14(6):1289–1297. doi:10.5114/aoms.2017.72220
   PubMed Web of Science ®Google Scholar
• Cao Q, You X, Xu L, Wang L, Chen Y. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy. Autophagy. 2020;16(7):1236–1247. doi:10.1080/15548627.2019.1659654
   PubMed Web of Science ®Google Scholar
• Guo Q, Ke XX, Fang SX, et al. PAQR3 inhibits non-small cell lung cancer growth by regulating the NF-κB/p53/Bax Axis. Front Cell Dev Biol. 2020;8:581919. doi:10.3389/fcell.2020.581919
   PubMed Web of Science ®Google Scholar
• Wu HG, Zhang WJ, Ding Q, et al. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma. Oncol Rep. 2014;32(6):2687–2695. doi:10.3892/or.2014.3532
   PubMed Web of Science ®Google Scholar
• Yu L, Zhou L, Cheng Y, et al. MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma. Am J Cancer Res. 2014;4(6):897–906.
   PubMed Web of Science ®Google Scholar
• Wu YL, Hong LL, Ling ZN, et al. Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/Smad pathway. J Clin Lab Anal. 2022;36(9):e24617. doi:10.1002/jcla.24617
   PubMed Web of Science ®Google Scholar
• Huang W, Guo W, You X, et al. PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells. Oncotarget. 2016;8(33):53948–53958. doi:10.18632/oncotarget.9807
   PubMedGoogle Scholar
• Jin L, Tong L. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability. Immun Inflamm Dis. 2021;9(3):827–839. doi:10.1002/iid3.437
   PubMed Web of Science ®Google Scholar
• Xie X, Zhang Y, Jiang Y, et al. Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse. Carcinogenesis. 2008;29(8):1632–1638. doi:10.1093/carcin/bgn139
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhuang K, Li H. PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma. Tumour Biol. 2016;37(1):561–565. doi:10.1007/s13277-015-3770-y
   PubMedGoogle Scholar
• Bai G, Yang M, Zheng C, Zhang L, Eli M. Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma. Oncol Lett. 2018;15(4):5703–5711. doi:10.3892/ol.2018.8004
   PubMed Web of Science ®Google Scholar
• Zhou F, Wang S, Wang J. PAQR3 inhibits the proliferation and tumorigenesis in esophageal cancer cells. Oncol Res. 2017;25(5):663–671. doi:10.3727/096504016X14761384026719
   PubMed Web of Science ®Google Scholar
• Bai G, Chu J, Eli M, Bao Y, Wen H. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling. Biomed Pharmacother. 2017;94:813–819. doi:10.1016/j.biopha.2017.07.154
   PubMed Web of Science ®Google Scholar
• Li Z, Ling ZQ, Guo W, et al. PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression. Oncotarget. 2015;6(14):12357–12368. doi:10.18632/oncotarget.3657
   PubMedGoogle Scholar
• Zhang C, Liu P, Huang J, et al. Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis. Cell Death Dis. 2021;12(10):888. doi:10.1038/s41419-021-04193-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang X, Qin X, et al. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene. 2010;29(39):5404–5415. doi:10.1038/onc.2010.270
   PubMed Web of Science ®Google Scholar
• Takai M, Terai Y, Kawaguchi H, et al. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J Ovarian Res. 2014;7:76. doi:10.1186/1757-2215-7-76
   PubMed Web of Science ®Google Scholar
• Yan H, Li H, Silva MA, et al. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. J Exp Clin Cancer Res. 2019;38(1):356. doi:10.1186/s13046-019-1356-z
   PubMed Web of Science ®Google Scholar
• Cao R, Yuan L, Ma B, Wang G, Qiu W, Tian Y. An EMT-related gene signature for the prognosis of human bladder cancer. J Cell Mol Med. 2020;24(1):605–617. doi:10.1111/jcmm.14767
   PubMed Web of Science ®Google Scholar
• Yi C, Wan X, Zhang Y, et al. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis. Int J Biochem Cell Biol. 2018;102:138–150. doi:10.1016/j.biocel.2018.07.009
   PubMed Web of Science ®Google Scholar
• Cho ES, Kang HE, Kim NH, Yook JI. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT). Arch Pharm Res. 2019;42(1):14–24. doi:10.1007/s12272-018-01108-7
   PubMed Web of Science ®Google Scholar
• Zhao C, Li Y, Chen G, Wang F, Shen Z, Zhou R. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3. Oncol Rep. 2017;38(1):352–358. doi:10.3892/or.2017.5673
   PubMed Web of Science ®Google Scholar
• Guo W, You X, Xu D, et al. PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. Carcinogenesis. 2016;37(4):397–407. doi:10.1093/carcin/bgw013
   PubMed Web of Science ®Google Scholar
• Chen J, Wang F, Xu J, He Z, Lu Y, Wang Z. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis. Oncol Rep. 2016;36(3):1612–1618. doi:10.3892/or.2016.4951
   PubMed Web of Science ®Google Scholar
• Qi LQ, Sun B, Yang BB, Lu S. MiR-15b facilitates breast cancer progression via repressing tumor suppressor PAQR3. Eur Rev Med Pharmacol Sci. 2020;24(2):740–748. doi:10.26355/eurrev_202001_20054
   PubMed Web of Science ®Google Scholar
• Shi Z, Hodges VM, Dunlop EA, et al. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line. Mol Cancer Res. 2010;8(4):615–626. doi:10.1158/1541-7786.MCR-09-0264
   PubMed Web of Science ®Google Scholar
• Yu X, Li Z, Chan MT, Wu WK. PAQR3: a novel tumor suppressor gene. Am J Cancer Res. 2015;5(9):2562–2568.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Xie X, Zhang Y, et al. Regulation of G-protein signaling by RKTG via Sequestration of the Gβγ subunit to the golgi apparatus. Mol Cell Biol. 2010;30(1):78–90. doi:10.1128/MCB.01038-09
   PubMed Web of Science ®Google Scholar
• Wang X, Wang L, Zhu L, et al. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110α to the Golgi apparatus. Diabetes. 2013;62(2):444–456. doi:10.2337/db12-0244
   PubMed Web of Science ®Google Scholar
• Jiang Y, Xie X, Li Z, et al. Functional cooperation of RKTG with p53 in tumorigenesis and epithelial-mesenchymal transition. Cancer Res. 2011;71(8):2959–2968. doi:10.1158/0008-5472.CAN-10-4077
   PubMed Web of Science ®Google Scholar
• Yochum ZA, Cades J, Wang H, et al. Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene. 2019;38(5):656–670. doi:10.1038/s41388-018-0482-y
   PubMed Web of Science ®Google Scholar
• Tao Y, Han T, Zhang T, Ma C, Sun C. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway. Oncotarget. 2017;8(22):36410–36422. doi:10.18632/oncotarget.16850
   PubMedGoogle Scholar
• Lounglaithong K, Bychkov A, Sampatanukul P. Aberrant promoter methylation of the PAQR3 gene is associated with prostate cancer. Pathol Res Pract. 2018;214(1):126–129. doi:10.1016/j.prp.2017.10.010
   PubMed Web of Science ®Google Scholar
• Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3(3):83–92.
   PubMedGoogle Scholar
• Brenner B, Hoshen MB, Purim O, et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011;17(35):3976–3985. doi:10.3748/wjg.v17.i35.3976
   PubMed Web of Science ®Google Scholar
• Shen XC, Zhan SH, Xu ST, Gu GJ. Prognostic and clinicopathologic significance of PAQR3 and VEGF-A expression in pulmonary adenocarcinoma. Int J Clin Exp Pathol. 2020;13(7):1676–1681.
   PubMed Web of Science ®Google Scholar
• Li RH, Zhang AM, Li S, et al. PAQR3 gene expression and its methylation level in colorectal cancer tissues. Oncol Lett. 2016;12(3):1773–1778. doi:10.3892/ol.2016.4843
   PubMed Web of Science ®Google Scholar